Pope, T. M.,
“Clinicians May Not Administer Life-Sustaining Treatment Without Consent: Civil, Criminal, and Disciplinary Sanctions,” Journal of Health and Biomedical Law 9 (
2013):
213-196;
Meisel, A.,
Cerminara, K., and
Pope, T. M.,
The Right to Die: The Law of End-of-Life Decisionmaking, 3rd ed. (New York: Wolters Kluwer Law & Business, 2017): loose-leaf publication from 2004, with annual supplements). From Meisel
et al., a short historical sketch running up to the inclusion by 1990 of lifesaving treatment in even nonterminal situations can be constructed. Initial steps were to define “life-sustaining treatment” as treatment that “will serve only to prolong the process of dying” (para. 7.06[A-3]) and to dispense with the usefulness of “the purported distinction between ordinary and extraordinary treatments…. Antibiotics [for example] may be forgone on the same basis and pursuant to the same standards of decisionmaking as any other therapy” (para. 6.03[F]). In 1978,
Satz v. Permutter 362 So. 2d 160 (Fla. Ct. App. 1978), affirmed 379 So. 2d 359 (Fla. 1980), ruled that an exercise of the right to refuse lifesaving treatment that leads to death is not attempted suicide if the patient’s affliction is not self-induced (para. 12.02[C-4]). Beginning in 1985, “courts in a … growing number of cases have not only recognized, but also have ceased trying to circumvent, the right of competent patients to refuse treatment when refusal would almost certainly result in their deaths but treatment was almost certain to restore their health to the status quo ante” (para. 5.01[A]). By 1990, in
In re Browning 568 So. 2d 4.10 (Fla. 1990), the right of a competent patient to refuse treatment had expanded further to be virtually absolute, encompassing the right to refuse “regardless of his or her medical condition” (para. 5.01[A]), including not being limited to terminal illness.
Google Scholar